Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: Interrupted time series evaluation of effectiveness

被引：48

作者：

Harris A.H.S. ^{[1
]}

Bowe T. ^{[1
]}

Hagedorn H. ^{[2
]}

Nevedal A. ^{[1
]}

Finlay A.K. ^{[1
]}

Gidwani R. ^{[1
]}

Rosen C. ^{[1
]}

Kay C. ^{[3
]}

Christopher M. ^{[3
]}

机构：

[1] Center for Innovation to Implementation, Health Services Research and Development, VA Palo Alto Health Care System, Menlo Park, CA

[2] Center for Chronic Disease Outcomes Research, Health Services Research and Development, VA Minneapolis Health Care System, Minneapolis, MN

[3] Pharmacy Benefits Management, Academic Detailing Program, VA San Diego Health Care System, San Diego, CA

来源：

Addiction Science & Clinical Practice | / 11卷 / 1期

关键词：

Alcohol use disorder; Guideline adherence; Implementation; Medication assisted treatment; Pharmacotherapy; Practice guidelines; Quality improvement;

D O I：

10.1186/s13722-016-0063-8

中图分类号：

学科分类号：

摘要：

Background: Active consideration of effective medications to treat alcohol use disorder (AUD) is a consensus standard of care, yet knowledge and use of these medications are very low across diverse settings. This study evaluated the overall effectiveness a multifaceted academic detailing program to address this persistent quality problem in the US Veterans Health Administration (VHA), as well as the context and process factors that explained variation in effectiveness across sites. Methods: An interrupted time series design, analyzed with mixed-effects segmented logistic regression, was used to evaluate changes in level and rate of change in the monthly percent of patients with a clinically documented AUD who received naltrexone, acamprosate, disulfiram, or topiramate. Using data from a 20 month post-implementation period, intervention sites (n = 37) were compared to their own 16 month pre-implementation performance and separately to the rest of VHA. Results: From immediately pre-intervention to the end of the observation period, the percent of patients in the intervention sites with AUD who received medication increased over 3.4 % in absolute terms and 68 % in relative terms (i.e., 4.9-8.3 %). This change was significant compared to the pre-implementation period in the intervention sites and secular trends in control sites. Sites with lower pre-implementation adoption, more person hours of detailing, but fewer people detailed, had larger immediate increases in medication receipt after implementation. The average number of detailing encounters per person was associated with steeper increases in slope over time. Conclusions: This study found empirical support for a multifaceted quality improvement strategy aimed at increasing access to and utilization of pharmacotherapy for AUD. Future studies should focus on determining how to enhance the programs effects, especially in non-responsive locations. © 2016 The Author(s).

引用

共 23 条

[11]

Ducharme L.J., Knudsen H.K., Roman P.M., Trends in the adoption of medications for alcohol dependence, J Clin Psychopharmacol, 26, pp. S13-S19, (2006)

[12]

Knudsen H.K., Roman P.M., Service delivery and pharmacotherapy for alcohol use disorder in the era of health reform: Data from a national sample of treatment organizations, Subst Abus, 37, pp. 230-237, (2016)

[13]

Rubinsky A.D., Chen C., Batki S.L., Et al., Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses, J Psychiatr Res, 69, pp. 150-157, (2015)

[14]

VA/DOD Clinical Practice Guideline for the Management of Substance Use Disorders, (2009)

[15]

Harris A.H., Oliva E., Bowe T., Et al., Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: Patterns of receipt and persistence, Psychiatr Serv, 63, pp. 679-685, (2012)

[16]

Trafton J.A., Greenberg G., Harris A.H., Et al., VHA mental health information system: Applying health information technology to monitor and facilitate implementation of VHA uniform mental health services handbook requirements, Med Care, 51, pp. S29-S36, (2013)

[17]

Ma O., Rogers S., Jamtvedt G., Oxman A.D., Odgaard-Jensen J., Kristoffersen D.T., Forsetlund L., Bainbridge D., Freemantle N., Davis D.A., Et al., Educational outreach visits: Effects on professional practice and health care outcomes, Cochrane Database Syst Rev., 4, (2007)

[18]

Bidassie B., Williams L.S., Woodward-Hagg H., Et al., Key components of external facilitation in an acute stroke quality improvement collaborative in the Veterans Health Administration, Implement Sci, 10, (2015)

[19]

Stetler C.B., Legro M.W., Rycroft-Malone J., Et al., Role of "external facilitation" in implementation of research findings: A qualitative evaluation of facilitation experiences in the Veterans Health Administration, Implement Sci, 1, (2006)

[20]

Schwartz T.L., Kuhles D.J., Wade M., Et al., Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits, Ann Clin Psychiatry, 13, pp. 159-162, (2001)

← 1 2 3 →